Developed by field experts from academic, regulatory, clinical, and commercial domains, this training program will focus on introducing key topics in cell and gene therapy manufacturing and development. Over the coming years, ISCT and CMaT will work together to offer hands-on practical training with specific focus on manufacturing, business development, licensing, and regulatory pathways.
The program aims to address key topics in CGT manufacturing and development and will include asynchronous lectures (comprised of a Theory and an Application component) as well as live instructor office hours/ expert panel Q&A sessions. There will be 4 modules:
“ISCT has long identified and taken measures to alleviate the skills shortages across the cell and gene therapy sector. ISCT has run a range of courses across the CGT sector, including forming our ISCT Early-Stage Professionals (ESP) Committee, responsible for our extensive Mentoring Program. Despite these efforts, growth in the CGT sector continues to outpace the professionals entering. This is a major issue for the sector that could become critical in the near future."-Bruce Levine, President, ISCT
“A well-trained, readily available, diverse workforce is crucial to the success of the emerging cell and gene therapy industry, especially given its highly specialized skill sets, GMP and regulatory requirements, and complex manufacturing and supply chain infrastructure. Our partnership with ISCT brings the largest cell manufacturing research and education consortium together with the largest global cell & gene therapy society to deliver critically needed workforce training for CGT. Together, we hope to develop a robust, on-demand, client-centric training platform for industry and clinical manufacturers.” -Krishnendu Roy, Robert A. Milton Chair, CMaT
This LIVE session provides the opportunity for program participants to ask questions directly to the speakers of Module 1.MODERATORKrishnendu Roy, PhD, Director, NSF Engineering Research Center (ERC) for Cell Manufacturing Technologies (CMaT), USA
THEORYAaron Levine, PhD, Associate Professor, Georgia Tech, USAAPPLICATIONBambi Grilley, RPh, RAC, CIP, CCRC, CCRP, Director, Clinical Research & Early Product Development, Center for Cell & Gene Therapy, Baylor College of Medicine, USA
© 2021 ISCT. All rights reserved.
Site by eConverse Media